Thus, based on published tumor-related results, a high level of expression of PD-L1 consistently suggests a poor prognosis for the patient, and the expression of PD-L1 is a potential predictor and therapeutic target for ICC. This evidence concerns the gene CD274 and intrahepatic cholangiocarcinoma.